Transport of deoxycoformycin in human erythrocytes
- 1 December 1984
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 33 (24) , 4069-4079
- https://doi.org/10.1016/0006-2952(84)90023-6
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Biochemical pharmacology and toxicology of 8-azaadenosine alone and in combination with 2′-deoxycoformycin(pentostatin)Biochemical Pharmacology, 1982
- Inhibitors of adenosine deaminasePharmacology & Therapeutics, 1982
- Clinical pharmacology of deoxycoformycinBlood, 1981
- The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancyBlood, 1981
- The clinical pharmacology of the adenosine deaminase inhibitor 2?-deoxycoformycinCancer Chemotherapy and Pharmacology, 1980
- N-methylformycinsBiochemical Pharmacology, 1979
- Tight-binding inhibitors—IV. Inhibition of adenosine deaminases by various inhibitorsBiochemical Pharmacology, 1977
- Tight-binding inhibitors—II: Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycinBiochemical Pharmacology, 1975
- Adenosine deaminase from human erythrocytes: Purification and effects of adenosine analogsBiochemical Pharmacology, 1975
- ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITYThe Lancet, 1972